Emilio Fernandez-Egea

1 month ago | cambridge.org | Shanquan Chen |Emilio Fernandez-Egea |Sara Rotenberg |Rudolf N Cardinal

Hostname: page-component-7b9c58cd5d-v2ckm Total loading time: 0 Render date: 2025-03-19T08:59:44.764Z Has data issue: false hasContentIssue false Published online by Cambridge University Press:  19 March 2025 Shanquan Chen [Opens in a new window] ,Emilio Fernandez-Egea [Opens in a new window] ,Sara Rotenberg [Opens in a new window] ,Rudolf N. Cardinal [Opens in a new window] ,Daiane Borges Machado [Opens in a new window] ,Tracey Smythe [Opens in a new window] ,Tamsin J.

Oct 3, 2024 | cambridge.org | Emilio Fernandez-Egea |Robert McCutcheon

In this issue, Oloyede and colleaguesReference Oloyede, Bachmann, Dzahini, Lopez Alcaraz, Singh and Vallianatu1 advocate for updating the haematological requirements for clozapine to increase access to this important drug. Their research indicates that the current system overestimates the incidence of clozapine-induced agranulocytosis (CIA), adding to the growing body of evidence suggesting a lack of significant CIA risk in the medium and long term.

Oct 2, 2024 | cambridge.org | Emilio Fernandez-Egea |Robert J. Flanagan |David Taylor |Fiona Gaughran

It is undeniable that clozapine can lead to fatal outcomes if its toxic effects are not promptly identified and managed. While acknowledging the risks associated with clozapine, media reports can overestimate the number of fatal outcomes due to the drug.